ALPN stock forecast
Our latest prediction for Alpine Immune Sciences, Inc.'s stock price was made on the May 30, 2019 when the stock price was at 4.99$.
In the short term (2weeks), ALPN's stock price should outperform the market by 3.40%. During that period the price should oscillate between -8.39% and +16.80%.
In the medium term (3months), ALPN's stock price should outperform the market by 1.85%. During that period the price should oscillate between -20.33% and +39.64%.
Get email alertsAbout Alpine Immune Sciences, Inc.
Alpine Immune Sciences, Inc. is a development-stage pharmaceutical company, which engages in the discovering of protein-based immunotherapies therapies targeting the immune synapse to treat cancer, autoimmune, and inflammatory disorders. It offers Immunotherapy, Immune Synapse, vIgD Platform Technology, and TIP Program. The company was founded in 2015 and is headquartered in Seattle, WA.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -2.95$ per share.
The book value per share is 4.80$
Three months stock forecastMay 30, 2019
Financials
| Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -44M | - | -44M | -2.95 | - | - | 15M | 4.80 | -35M | - | -36M |